Chesapeake Asset Management LLC Amgen Inc Transaction History

Chesapeake Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Oct 15, 2025	BUY	$262.28 - $309.85 $6,556 - $7,746	25 New	25 $6,000
Q1 2025 Jan 05, 2026	BUY	$258.59 - $327.36 $1,034 - $1,309	4 Added 13.79%	33 $10.3 Million
Q4 2024 Jan 05, 2026	BUY	$258.78 - $328.31 $6,469 - $8,207	25 Added 625.0%	29 $7.56 Million
Q3 2024 Jan 05, 2026	SELL	$309.38 - $337.38 $102,714 - $112,010	-332 Reduced 98.81%	4 $1.29 Million
Q2 2024 Jan 05, 2026	BUY	$262.75 - $319.31 $81,715 - $99,305	311 Added 1244.0%	336 $105 Million

Q1 2024 Jan 05, 2026	SELL	$268.87 - $324.56 $77,972 - $94,122	-290 Reduced 47.46%	321 $91.3 Million
Q4 2023 Jan 05, 2026	BUY	$255.7 - $288.46 $116,343 - $131,249	455 Added 291.67%	611 $176 Million
Q1 2023 Jan 05, 2026	BUY	$225.79 - $275.2 $29,578 - $36,051	131 Added 524.0%	156 $37.7 Million

3,285

428M

6.11M

5.85M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Chesapeake Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Asset Management LLC with notifications on news.